Enhancement of anti-inflammatory activity of PEP-1-FK506 binding protein by silk fibroin peptide

Journal of Microbiology and Biotechnology

Volumn 22, Issue 4, 2012, Pages 494-500

  Kim, Dae Won ^a   Hwang, Hyun Sook ^a   Kim, Duk Soo ^b   Sheen, Seung Hoon ^c   Heo, Dong Hwa ^c   Hwang, Gyojun ^c   Kang, Suk Hyung ^c   Kweon, Haeyong ^d   Jo, You Young ^d   Kang, Seok Woo ^d   Lee, Kwang Gill ^d   Park, Jinseu ^a   Eum, Won Sik ^a   Cho, Yong Jun ^c   Choi, Soo Young ^a  

^a Hallym University   (South Korea)

^b Soonchunhyang University   (South Korea)

^c Hallym University Medical Center   (South Korea)

^d National Institute of Animal Science   (South Korea)

Author keywords

Inflammation; PEP 1 FK506BP; Protein transduction; Reactive oxygen species; Silk fibroin peptide; TPA

Indexed keywords

CYCLOOXYGENASE 2; FK 506 BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 6; PEP 1 FK506 BINDING PROTEIN; SILK FIBROIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EAR DISEASE; EAR EDEMA; EDEMA; HUMAN; HUMAN CELL; KERATINOCYTE; MALE; MOUSE; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BOMBYX; CELL LINE; DRUG SYNERGISM; EDEMA; FIBROINS; HUMANS; MALE; MICE; MICE, INBRED ICR; PEPTIDES; SKIN DISEASES; TACROLIMUS BINDING PROTEIN 1A;

EID: 84860152557     PISSN: 10177825     EISSN: 17388872     Source Type: Journal    
DOI: 10.4014/jmb.1111.11024     Document Type: Article

References (30)

1. Bickers, D. R. and M. Athar. 2006. Oxidative stress in the pathogenesis of skin disease. J. Invest. Dermatol. 126: 2565-2575.
2. Breiman, A. and I. Camus. 2002. The involvement of mammalian and plant FK506-binding proteins (FKBPs) in development. Transgenic Res. 11: 321-335.
3. Dietz, G. P. 2010. Cell-penetrating peptide technology to deliver chaperones and associated factors in diseases and basic research. Curr. Pharm. Biotechol. 11: 167-174.
4. Dunlop, E. A. and A. R. Tee. 2009. Mammalian target of rapamycin complex 1: Signalling inputs, substrates and feedback mechanisms. Cell Signal. 21: 827-835.
5. Floyd, R. A. 1990. Role of oxygen free radicals in carcinogenesis and brain ischemia. FASEB J. 4: 2587-2597.
6. Garcia, J. A. and D. Danielpour. 2008. Mammalian target of rapamycin inhibition as a therapeutic strategy in the management of urologic malignancies. Mol. Cancer Ther. 7: 1347-1354.
7. Grilli, M. and M. Memo. 1999. Possible role of NF-kappaB and p53 in the glutamate-induced pro-apoptotic neuronal pathway. Cell Death Differ. 6: 22-27.
8. Grilli, M. and M. Memo. 1999. Nuclear factor-kappaB/Rel proteins: A point of convergence of signalling pathways relevant in neuronal function and dysfunction. Biochem. Pharmacol. 57: 1-7.
9. Hyun, C. K., I. Y. Kim, and S. C. Frost. 2004. Soluble fibroin enhances insulin sensitivity and glucose metabolism in 3T3-L1 adipocytes. J. Nutr. 134: 3257-3263.
10. Igarashi, K., K. Yoshioka, K. Mizutani, M. Miyakoshi, T. Murakami, and T. Akizawa. 2006. Blood pressure-depressing activity of a peptide derived from silkworm fibroin in spontaneously hypertensive rats. Biosci. Biotechnol. Biochem. 70: 517-520.
11. Kang, C. B., H. Ye, S. Dhe-Paganon, and H. S. Yoon. 2008. FKBP family proteins: Immunophilins with versatile biological functions. Neurosignals 16: 318-325.
12. Kim, J. Y., J. Y. Choi, J. H. Jeong, E. S. Jang, A. S. Kim, S. G. Kim, et al. 2010. Low molecular weight silk fibroin increases alkaline phosphatase and type I collagen expression in MG63 cells. BMB Rep. 43: 52-56.
13. Kim, S. Y., H. J. Jeong, D. W. Kim, M. J. Kim, J. J. An, E. J. Sohn, et al. 2011. Transduced PEP-1-FK506BP inhibits the inflammatory response in the Raw 264.7 cell and mouse models. Immunobiology 216: 771-781.
14. Kim, S. Y., E. J. Sohn, D. W. Kim, H. J. Jeong, M. J. Kim, H. W. Kang, et al. 2011. Transduced PEP-1-FK506BP ameliorates atopic dermatitis in NC/Nga mice. J. Invest. Dermatol. 131: 1477-1485.
15. Lee, S. H., H. J. Jeong, D. W. Kim, E. J. Sohn, M. J. Kim, D. S. Kim, et al. 2010. Enhancement of HIV-1 Tat fusion protein transduction efficiency by bog blueberry anthocyanins. BMB Rep. 43: 561-566.
16. Long, C., L. G. Cook, S. L. Hamilton, G. Y. Wu, and B. M. Mitchell. 2007. FK506 binding protein 12/12.6 depletion increases endothelial nitric oxide synthase threonine 495 phosphorylation and blood pressure. Hypertension 49: 569-576.
17. Lopez-Ilasaca, M., C. Schiene, G. Kullertz, T. Tradler, G. Fischer, and R. Wetzker. 1998. Effects of FK506-binding protein 12 and FK506 on autophosphorylation of epidermal growth factor receptor. J. Biol. Chem. 273: 9430-9434.
18. Lu, S., X. Wang, Q. Lv, X. Hu, N. Uppal, F. Omenetto, and D. L. Kaplan. 2009. Stabilization of enzymes in silk film. Biomacromolecules 10: 1032-1042.
19. Mates, J. M. 2000. Effects of antioxidant enzymes in the molecular control of reactive oxygen species toxicology. Toxicology 83: 83-104.
20. Nathan, C. 2002. Points of control in inflammation. Nature 420: 846-852.
21. Schiene-Fischer, C. and C. Yu. 2001. Receptor accessory folding helper enzymes: The functional role of peptidyl prolyl cis/trans isomerase. FEBS Lett. 495: 1-6.
22. Schwarze, S. R., K. A. Hruska, and S. F. Dowdy. 2000. Protein transduction: Unrestricted delivery into all cells? Trends Cell Biol. 10: 290-295.
23. Sohn, E. J., D. W. Kim, Y. N. Kim, S. M. Kim, S. S. Lim, T. C. Kang, et al. 2011. Effects of pergolide mesylate on transduction efficiency of PEP-1-catalase protein. Biochem. Biophys. Res. Commun. 406: 336-340.
24. Song, H. Y., J. A. Lee, S. M. Ju, K. Y. Yoo, M. H. Won, H. J. Kwon, et al. 2008. Topical transduction of superoxide dismutase mediated by HIV-1 Tat protein transduction domain ameliorates 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced inflammation in mice. Biochem. Pharmacol. 75: 1348-1357.
25. Stanley, P. L., S. Steiner, and M. Havens. 1991. Tramposch KM: Mouse skin inflammation induced by multiple topical applications of 12-O-tetradecanoylphorbol-13-acetate. Skin Pharmacol. 4: 262-271.
26. Wadia, J. S. and S. F. Dowdy. 2002. Protein transduction technology. Curr. Opin. Biotechnol. 13: 52-56.
27. Wadia, J. S. and S. F. Dowdy. 2003. Modulation of cellular function by TAT mediated transduction of full length proteins. Curr. Protein Pept. Sci. 4: 97-104.
28. Wang, T., P. K. Donahoe, and A. S. Zervos. 1994. Specific interaction of type I receptors of the TGF-beta family with the immunophilin FKBP-12. Science 265: 674-676.
29. Yamaguchi, T., A. Kurisaki, N. Yamakawa, K. Minakuchi, and H. Sugino. 2006. FKBP12 functions as an adaptor of the Smad7-Smurf1 complex on activin type I receptor. J. Mol. Endocrinol. 36: 569-579.
30. Zhou, H., A. Lin, Z. Gu, S. Chen, N. H. Park, and R. Chiu. 2000. 12-O-Tetradecanoylphorbol-13-acetate (TPA)-induced c- Jun N-terminal kinase (JNK) phosphatase renders immortalized or transformed epithelial cells refractory to TPA-inducible JNK activity. J. Biol. Chem. 275: 22868-22875.